Effect of Delayed Cord Clamping on Haematological Status in Low Birth Weight Infants
NCT ID: NCT01487980
Last Updated: 2012-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2012-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early cord clamping
Within 30 seconds after birth.
Cord clamping
Early vs Delayed
Delayed cord clamping
Between 2 and 3 minutes after birth
Cord clamping
Early vs Delayed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cord clamping
Early vs Delayed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. history of postpartum haemorrhage (PPH)
3. (gestational) diabetes
4. pre-eclampsia
5. abruptio placentae
6. caesarian section
7. necessity of early clamping due to tight nuchal cord
8. need for resuscitation immediately after birth
9. major congenital abnormalities
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otto Kranendonk Fonds - Dutch Association of Tropical Health (request pending)
UNKNOWN
Stanger Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
S. Tiemersma
Medical Officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sybrich Tiemersma, MD
Role: PRINCIPAL_INVESTIGATOR
Stanger Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanger Hospital
KwaDukuza, KwaZulu-Natal, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCC-LBW-SA
Identifier Type: -
Identifier Source: org_study_id